Federal Register
Notice: FDA is seeking public comment on the collection of information contained in a guidance for industry entitled Submitting and Reviewing Complete Responses to Clinical Holds. The guidance describes how to submit a complete response if an investigational new drug application is placed on clinical hold by FDA. Comments should be submitted by 7/24. To view this notice, click here.